House Approves $52 Billion Bill to Help Chip Manufacturers

(Bloomberg) — The US House of Representatives passed a bill that includes $52 billion in grants and incentives for domestic semiconductor manufacturing, sending it to President Joe Biden for his signature and delivering a win for his administration more than a year after legislation was first introduced in Congress.

“This legislation is a major victory for American families and the American economy,” House Speaker Nancy Pelosi said in a statement before the vote. “Once enacted, the Chips and Science Act will bolster our nation’s production of semiconductor chips — reinvigorating American manufacturing and creating nearly 100,000 good-paying, union jobs.”

The 243 to 187 vote attracted support from 24 Republicans who defied a last-minute push from GOP leaders to oppose the bill. House Minority Leader Kevin McCarthy initially took a hands-off approach to the bill but decided late Wednesday to whip against it after Senate Democrats announced a surprise agreement on a separate tax and spending bill that Republicans oppose.

The chips measure, the result of lengthy House-Senate negotiations, has been presented as both a way to reinvigorate the US industrial base and fortify the country’s national security interests against future supply chain disruptions overseas, where the vast majority of advanced semiconductors are currently produced. In addition to semiconductor funding, the bill includes money for research and workforce training and 5G wireless technology.

“We are ushering in a bold and prosperous future for American science and innovation,” Texas Democrat Eddie Bernice Johnson, the chair of the House Science Committee, said in a statement.

The bill includes legislation from Representatives Michael McCaul, a Texas Republican, and Doris Matsui, a California Democrat, to provide grants and incentives to semiconductor companies to build fabrication facilities, or “fabs,” in the US. That measure was combined with provisions from the Science Committee, along with several other measures.

McCaul called the bill “critical national security legislation” vital to helping the US counter China.

Still, McCarthy and other Republicans opposed the legislation, with some criticizing it for not being tough enough on China. Representative Jim Banks of Indiana, the chairman of the Republican Study Committee, called it a “fake China bill” in a tweet. McCarthy, in a speech on the House floor Thursday, called the subsidies for semiconductor manufacturing “corporate welfare.”

 

More stories like this are available on

bloomberg.com

Follow us on social media for the latest updates in B2B!

Image

Latest

data center infrastructure
AI Is Forcing a Rethink of Data Center Infrastructure at Every Level
December 29, 2025

The data center industry is being redefined by AI’s demand for faster, denser, and more scalable infrastructure. According to McKinsey, average rack power densities have more than doubled in just two years. It went from approximately 8 kW to 17 kW, and is expected to hit 30 kW by 2027. Global data center power demand is projected…

Read More
Emergency department
How Predictive AI Is Helping Hospitals Anticipate Admissions and Optimize Emergency Department Throughput
December 24, 2025

Emergency departments across the U.S. are under unprecedented strain, with overcrowding, staffing shortages, and inpatient bed constraints converging into a throughput crisis. The American Hospital Association reports that hospital capacity and workforce growth have lagged, intensifying delays from arrival to disposition. At the same time, advances in artificial intelligence are moving from experimental to operational—raising…

Read More
Mission
Why Is the Mission of Benchmark So Important
December 23, 2025

As pharmaceutical innovation accelerates, the margin for error narrows, making quality assurance not just a regulatory necessity but a public good. Benchmark’s mission sits at the intersection of progress and protection—helping manufacturers stay aligned with FDA standards so life-saving therapies reach patients faster and safer. By keeping cleanrooms compliant and companies out of trouble, Benchmark…

Read More
Benchmark
What Is It Like for You to Be Part of the Benchmark Products Teams Now
December 23, 2025

Being part of the Benchmark Products team today means working at the intersection of precision manufacturing and deeply human collaboration, especially in the high-stakes world of cleanroom and sterility assurance solutions. As the organization grows, employees describe a culture that still feels familial—one where clear communication, personal accountability, and genuine care for customers drive…

Read More